No Detail Found!

Effect of Intravenous Magnesium Sulphate on in-Hospital Mortality in Neonates with Perinatal Asphyxia: A Prospective Cohort Study

Author(s)
Javaria Rasheed Department of Paediatric Medicine, Nishtar Hospital, Multan, Pakistan
Muhammad Khalid Department of Paediatric Medicine, Nishtar Hospital, Multan, Pakistan
Barera Maryam Department of Paediatric Medicine, Nishtar Hospital, Multan, Pakistan
Shazia Parveen Department of Paediatric Medicine, Nishtar Hospital, Multan, Pakistan
Abstract
Background: Early neonatal deaths in Pakistan account for 7% of global neonatal mortality rate, with perinatal asphyxia being responsible for 23% of these cases. Controversy exists in the literature regarding role of magnesium sulphate administration on reducing in-hospital mortality in newborns with perinatal asphyxia. Objectives: To determine the effect of intravenous magnesium sulphate on in-hospital mortality in neonates with perinatal asphyxia. Methods: This prospective cohort study was conducted at the Department of Pediatric Medicine, Nishtar Hospital Multan over a period of six months from January 2022 to June 2022. A total of 183 consecutive fullterm neonates, weighing = 2500 grams, with Apgar score < 7 at 5-minutes after birth, presenting within 48hours of life were included in the study. Neonates presenting within 6-hours after birth received intravenous magnesium sulphate (MgSO4) - exposed group and neonates presenting after 6-hours did not get MgSO4 unexposed group. Baseline characteristics and survival outcome was recorded. Binary logistic regression analysis was run and Kaplan-Meier survival curve is constructed for the assessment of mortality. Results: There were 90 neonates in exposed group and 93 in unexposed group. Males constituted 53% of the study population. Overall mortality rate was 15.8% (n=29). Severe asphyxia (RR 8.5, 95% CI 4.0 - 18.0; p < 0.001) and spontaneous vaginal delivery (RR 1.8, 95% CI 1.1 - 2.9; p = 0.02) were the independent predictors of mortality. Mortality (7.8% vs. 23.6%, p-value 0.003) was significantly higher in unexposed group compared to exposed group. In exposed group the median survival time was 16 days (95% CI- 8.7 - 23.3) compared to 11 days (95% CI 9.9 - 12.0) in unexposed group (Log-rank test: ?2 = 6.03, df -1, p = 0.01). Conclusion: Magnesium sulphate was effective in lowering neonatal mortality due to moderate-severe perinatal asphyxia. In order to further validate its impact on mortality, multi-center studies are suggested.
Publication Details
Page(s) 136-141
Published Journal: Annals of King Edward Medical University, Volume: 29, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Magnesium sulphate, Mortality, Newborn, Asphyxia neonatorum
0

Citations

0

Downloads

55

Views